Antidiabetic effect of Lactobacillus casei CCFM0412 on mice with type 2 diabetes induced by a high-fat diet and streptozotocin

Nutrition

Volumn 30, Issue 9, 2014, Pages 1061-1068

  Chen, Pei ^a,b   Zhang, Qiuxiang ^a   Dang, Hui ^a,c   Liu, Xiaoming ^a   Tian, Fengwei ^a   Zhao, Jianxin ^a   Chen, Yongquan ^a   Zhang, Hao ^a   Chen, Wei ^a  

^a JIANGNAN UNIVERSITY   (China)

^b SHAANXI UNIVERSITY OF TECHNOLOGY   (China)

^c SHAANXI NORMAL UNIVERSITY   (China)

Author keywords

Antidiabetic effect; Blood glucose; Lactobacillus casei CCFM0412; Pioglitazone; Type 2 diabetes

Indexed keywords

ENDOTOXIN; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLYCOGEN; GLYCOSYLATED HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; INTERLEUKIN 10; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; PIOGLITAZONE; PROBIOTIC AGENT; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; ANTIDIABETIC AGENT; ANTIOXIDANT; GLUCOSE BLOOD LEVEL; LIPID; STREPTOZOCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; DYSLIPIDEMIA; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; HISTOPATHOLOGY; IMMUNOREGULATION; LACTOBACILLUS CASEI; LIPID DIET; LIPID METABOLISM; LIVER LEVEL; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; OXIDATIVE STRESS; PANCREAS INJURY; PANCREAS ISLET; PRIORITY JOURNAL; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; ANIMAL; BLOOD; C57BL MOUSE; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; DRUG EFFECTS; DYSLIPIDEMIAS; METABOLISM;

ANIMALS; ANTIOXIDANTS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; DIET, HIGH-FAT; DYSLIPIDEMIAS; ENDOTOXINS; GLUCOSE INTOLERANCE; HEMOGLOBIN A, GLYCOSYLATED; HYPOGLYCEMIC AGENTS; INSULIN; ISLETS OF LANGERHANS; LACTOBACILLUS CASEI; LIPIDS; MALE; MALONDIALDEHYDE; MICE, INBRED C57BL; OXIDATIVE STRESS; STREPTOZOCIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84905507812     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2014.03.022     Document Type: Article

References (40)

1. Polonsky K.S. The beta-cell in diabetes: from molecular genetics to clinical research. Diabetes 1995, 44:705-717.
2. Schenk S., Saberi M., Olefsky J.M. Insulin sensitivity: modulation by nutrients and inflammation. J Clin Invest 2008, 118:2992-3002.
3. Neyrinck A.M., Cani P.D., Dewulf E.M., De Backer F., Bindels L.B., Delzenne N.M. Critical role of Kupffer cells in the management of diet-induced diabetes and obesity. Biochem Biophys Res Commun 2009, 385:351-356.
4. Feingold K.R., Grunfeld C. Role of cytokines in inducing hyperlipidemia. Diabetes 1992, 41(Suppl 2):97-101.
5. van Exel E., Gussekloo J., de Craen A.J., Frölich M., Bootsma-Van Der Wiel A., Westendorp R.G., et al. Low production capacity of interleukin-10 associates with the metabolic syndrome and type 2 diabetes: the Leiden 85-plus study. Diabetes 2002, 51:1088-1092.
6. Menassa R., Nguyen V., Jevnikar A., Brandle J. A self-contained system for the field production of plant recombinant interleukin-10. Mol Breeding 2001, 8:177-185.
7. Stephens J.W., Khanolkar M.P., Bain S.C. The biological relevance and measurement of plasma markers of oxidative stress in diabetes and cardiovascular disease. Atherosclerosis 2009, 202:321-329.
8. Ejtahed H.S., Mohtadi-Nia J., Homayouni-Rad A., Niafar M., Asghari-Jafarabadi M., Mofid V. Probiotic yogurt improves antioxidant status in type 2 diabetic patients. Nutrition 2012, 28:539-543.
9. Phung O.J., Baker W.L., Tongbram V., Bhardwaj A., Coleman C.I. Oral antidiabetic drugs and regression from prediabetes to normoglycemia: a meta-analysis. Ann Pharmacother 2012, 46:469-476.
10. Luna B., Feinglos M.N. Oral agents in the management of type 2 diabetes mellitus. Am Fam Physician 2001, 63:1747-1756.
11. Yun S.I., Park H.O., Kang J.H. Effect of Lactobacillus gasseri BNR17 on blood glucose levels and body weight in a mouse model of type 2 diabetes. J Appl Microbiol 2009, 107:1681-1686.
12. Tabuchi M., Ozaki M., Tamura A., Yamada N., Ishida T., Hosoda M., et al. Antidiabetic effect of Lactobacillus GG in streptozotocin-induced diabetic rats. Biosci Biotechnol Biochem 2003, 67:1421-1424.
13. Yadav H., Jain S., Sinha P.R. Antidiabetic effect of probiotic dahi containing Lactobacillus acidophilus and Lactobacillus casei in high fructose fed rats. Nutrition 2007, 23:62-68.
14. Lutgendorff F., Trulsson L.M., van Minnen L.P., Rijkers G.T., Timmerman H.M., Franzén L.E., et al. Probiotics enhance pancreatic glutathione biosynthesis and reduce oxidative stress in experimental acute pancreatitis. Am J Physiol-Gastr L 2008, 295:G1111-G1121.
15. Furukawa S., Fujita T., Shimabukuro M., Iwaki M., Yamada Y., Nakajima Y., et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 2004, 114:1752-1761.
16. Urakawa H., Katsuki A., Sumida Y., Gabazza E.C., Murashima S., Morioka K., et al. Oxidative stress is associated with adiposity and insulin resistance in men. J Clin Endocrinol Metab 2003, 88:4673-4676.
17. Houstis N., Rosen E.D., Lander E.S. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature 2006, 440:944-948.
18. Bertoni A.G., Hundley W.G., Massing M.W., Bonds D.E., Burke G.L., Goff D.C. Heart failure prevalence, incidence, and mortality in the elderly with diabetes. Diabetes Care 2004, 27:699-703.
19. Srinivasan K., Ramarao P. Animal models in type 2 diabetes research: an overview. Indian J Med Res 2007, 125:451-472.
20. Stumvoll M., Mitrakou A., Pimenta W., Jenssen T., Yki-Järvinen H., Van Haeften T., et al. Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care 2000, 23:295-301.
21. Phillips D.I.W., Clark P.M., Hales C.N., Osmond C. Understanding oral glucose tolerance: Comparison of glucose or insulin measurements during the oral glucose tolerance test with specific measurements of insulin-resistance and insulin-secretion. Diabetic Med 1994, 11:286-292.
22. Woerle H.J., Neumann C., Zschau S., Tenner S., Irsigler A., Schirra J., et al. Impact of fasting and postprandial glycemia on overall glycemic control in type 2 diabetes importance of postprandial glycemia to achieve target HbA1 c levels. Diabetes Res Clin Pract 2007, 77:280-285.
23. Moller D.E. Potential role of TNF-alpha in the pathogenesis of insulin resistance and type 2 diabetes. Trends Endocrinol Metab 2000, 11:212-217.
24. Ko K.S., Lee M., Koh J.J., Kim S.W. Combined administration of plasmids encoding IL-4 and IL-10 prevents the development of autoimmune diabetes in nonobese diabetic mice. Mol Ther 2001, 4:313-316.
25. Kannel W.B. Lipids, diabetes, and coronary heart disease: insights from the Framingham Study. Am Heart J 1985, 110:1100-1107.
26. Giugliano D., Ceriello A., Paolisso G. Oxidative stress and diabetic vascular complications. Diabetes Care 1996, 19:257-267.
27. Matsuzaki T., Nagata Y., Kado S., Uchida K., Hashimoto S., Yokokura T. Effect of oral administration of Lactobacillus casei on alloxan-induced diabetes in mice. APMIS 1997, 105:637-642.
28. Matsuzaki T., Yamazaki R., Hashimoto S., Yokokura T. Antidiabetic effects of an oral administration of Lactobacillus casei in a non-insulin-dependent diabetes mellitus (NIDDM) model using KK-AY mice. Endocr J 1997, 44:357-365.
29. Konno A., Hishinuma K., Hashimoto Y., Kimura S., Nishimura T. Dietary restriction reduces the incidence of 3-methylcholanthrene-induced tumors in mice: close correlation with its potentiating effect on host T cell functions. Cancer Immunol Immunother 1991, 33:293-298.
30. Jong-Anurakkun N., Bhandari M.R., Kawabata J. Alpha-Glucosidase inhibitors from Devil tree (Alstonia scholaris). Food Chem 2007, 103:1319-1323.
31. Yoon J.C., Puigserver P., Chen G., Donovan J., Wu Z., Rhee J., et al. Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1. Nature 2001, 413:131-138.
32. Shulman G.I. Cellular mechanisms of insulin resistance. J Clin Invest 2000, 106:171-176.
33. Cani P.D., Amar J., Iglesias M.A., Poggi M., Knauf C., Bastelica D., et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007, 56:1761-1772.
34. Cani P.D., Neyrinck A.M., Fava F., Knauf C., Burcelin R.G., Tuohy K.M., et al. Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia 2007, 50:2374-2383.
35. Mishima Y., Kuyama A., Tada A., Takahashi K., Ishioka T., Kibata M. Relationship between serum tumor necrosis factor-alpha and insulin resistance in obese men with type 2 diabetes mellitus. Diabetes Res Clin Pract 2001, 52:119-123.
36. Moore K.W., de Waal Malefyt R., Coffman R.L., O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001, 19:683-765.
37. Zhang S.W., Liu L., Su Y.L., Li H.J., Sun Q., Liang X., et al. Antioxidative activity of lactic acid bacteria in yogurt. Afr J Microbiol Res 2011, 5:5194-5201.
38. Aydin A., Orhan H., Sayal A., Ozata M., Sahin G., Isimer A. Oxidative stress and nitric oxide related parameters in type II diabetes mellitus: effects of glycemic control. Clin Biochem 2001, 34:65-70.
39. Peuchant E., Delmas-Beauvieux M.C., Couchouron A., Dubourg L., Thomas M.J., Perromat A., et al. Short-term insulin therapy and normoglycemia. Effects on erythrocyte lipid peroxidation in NIDDM patients. Diabetes Care 1997, 20:202-207.
40. Memisoǧullari R., Taysi S., Bakan E., Capoglu I. Antioxidant status and lipid peroxidation in type II diabetes mellitus. Cell Biochem Funct 2003, 21:291-296.